| New effective chemically synthesized anti-smallpox compound NIOCH-14 OY Mazurkov, AS Kabanov, LN Shishkina, AA Sergeev, MO Skarnovich, ... Journal of General Virology 97 (5), 1229-1239, 2016 | 72 | 2016 |
| Identification of cancer stem cells and a strategy for their elimination EV Dolgova, EA Alyamkina, YR Efremov, VP Nikolin, NA Popova, ... Cancer Biology & Therapy 15 (10), 1378-1394, 2014 | 65 | 2014 |
| Immunogenicity and protectivity of the peptide vaccine against SARS-CoV-2 AB Ryzhikov, EА Ryzhikov, MP Bogryantseva, ED Danilenko, ... Annals of the Russian academy of medical sciences 76 (1), 5-19, 2021 | 49 | 2021 |
| Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression G Kochneva, E Zonov, A Grazhdantseva, A Yunusova, G Sibolobova, ... Oncotarget 5 (22), 11269, 2014 | 49 | 2014 |
| “Delayed death” phenomenon: A synergistic action of cyclophosphamide and exogenous DNA EV Dolgova, AS Proskurina, VP Nikolin, NA Popova, EA Alyamkina, ... Gene 495 (2), 134-145, 2011 | 44 | 2011 |
| Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with … EV Dolgova, YR Efremov, KE Orishchenko, OM Andrushkevich, ... Gene 528 (2), 74-83, 2013 | 41 | 2013 |
| A strategy to eradicate well-developed Krebs-2 ascites in mice EA Potter, EV Dolgova, AS Proskurina, AM Minkevich, YR Efremov, ... Oncotarget 7 (10), 11580, 2016 | 31 | 2016 |
| Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts EA Alyamkina, VP Nikolin, NA Popova, AM Minkevich, AV Kozel, ... Cancer Cell International 15, 1-14, 2015 | 31 | 2015 |
| Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess Monkeypox Drug Efficacy AA Sergeev, AS Kabanov, LE Bulychev, AA Sergeev, OV Pyankov, ... Transboundary and emerging diseases 64 (1), 226-236, 2017 | 29 | 2017 |
| The possibility of using the ICR mouse as an animal model to assess antimonkeypox drug efficacy AA Sergeev, AS Kabanov, LE Bulychev, AA Sergeev, OV Pyankov, ... Transboundary and Emerging Diseases 63 (5), e419-e430, 2016 | 29 | 2016 |
| Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells EA Potter, EV Dolgova, AS Proskurina, YR Efremov, AM Minkevich, ... Oncotarget 8 (6), 9425, 2017 | 24 | 2017 |
| The selection and optimization of the detection system for self-contained multiplexed dot-immunoassay AG Poltavchenko, BN Zaitsev, AV Ersh, DV Korneev, OS Taranov, ... Journal of Immunoassay and Immunochemistry 37 (5), 540-554, 2016 | 23 | 2016 |
| Cowpox in a human, Russia, 2015 AY Popova, RA Maksyutov, OS Taranov, TV Tregubchak, AV Zaikovskaya, ... Epidemiology & Infection 145 (4), 755-759, 2017 | 22 | 2017 |
| Oncolytic effect of adenoviruses serotypes 5 and 6 against U87 glioblastoma cancer stem cells MV Romanenko, EV Dolgova, ID Osipov, GS Ritter, MS Sizova, ... Anticancer research 39 (11), 6073-6086, 2019 | 19 | 2019 |
| An outbreak of sheep pox in Zabajkalskij kray of Russia RA Maksyutov, EV Gavrilova, AP Agafonov, OS Taranov, AG Glotov, ... Transboundary and Emerging Diseases 62 (4), 453-456, 2015 | 17 | 2015 |
| Cancer stem cells: emergent nature of tumor emergency YR Efremov, AS Proskurina, EA Potter, EV Dolgova, OV Efremova, ... Frontiers in genetics 9, 544, 2018 | 16 | 2018 |
| Using ICR and SCID mice as animal models for smallpox to assess antiviral drug efficacy KA Titova, AA Sergeev, AS Zamedyanskaya, DO Galahova, AS Kabanov, ... Journal of General Virology 96 (9), 2832-2843, 2015 | 16 | 2015 |
| Cancer-suppressive effect of RNase A and DNase I OA Shklyaeva, NL Mironova, EM Malkova, OS Taranov, EI Ryabchikova, ... Doklady. Biochemistry and Biophysics 420 (1), 108, 2008 | 16 | 2008 |
| Selection of substrate material for protein arrays AG Poltavchenko, BN Zaitsev, AV Ersh, OS Taranov, DV Korneev, ... Protection of Metals and Physical Chemistry of Surfaces 52, 302-308, 2016 | 14 | 2016 |
| Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma EA Potter, AS Proskurina, GS Ritter, EV Dolgova, VP Nikolin, NA Popova, ... Oncotarget 9 (47), 28486, 2018 | 13 | 2018 |
Tatyana DubatolovaInstitute of molecular&cellular biology, SB RAS, Novosibirsk, RussiaVerified email at mcb.nsc.ru
